Pharmacokinetics of T-2 toxin and its metabolite HT-2 toxin, after intravenous administration in dogs. 1986

A Sintov, and M Bialer, and B Yagen

The pharmacokinetics of T-2 toxin and HT-2 toxin were investigated comparatively in five dogs, after iv administration of the toxins (0.4 mg/kg). T-2 toxin was very rapidly and almost completely biotransformed to HT-2 toxin (fm = 83.6 +/- 3.9%). The following mean pharmacokinetic parameters were determined in this study for T-2 toxin and HT-2 toxin, respectively: half-life 5.3 +/- 2.1 and 19.6 +/- 4.7 min, clearance 0.107 +/- 0.056 and 0.167 +/- 0.074 liters/min/kg, and volume of distribution 0.86 +/- 0.63 and 4.47 +/- 1.38 liters/kg. The high clearance values suggest that the metabolism of T-2 toxin and HT-2 toxin is carried out in blood and/or through diffusion by nonspecific carboxyesterases. The results of this study suggest the possibility of a sustenance of T-2 toxin metabolism by its binding to blood cells.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007700 Kinetics The rate dynamics in chemical or physical systems.
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.
D012717 Sesquiterpenes Fifteen-carbon compounds formed from three isoprenoid units with general formula C15H24. Farnesanes,Farnesene,Farnesenes,Sesquiterpene,Sesquiterpene Derivatives,Sesquiterpenoid,Sesquiterpenoids,Derivatives, Sesquiterpene
D013605 T-2 Toxin A potent mycotoxin produced in feedstuffs by several species of the genus FUSARIUM. It elicits a severe inflammatory reaction in animals and has teratogenic effects. Fusaritoxin,Fusariotoxin,T-2 Toxin, alpha,4 beta-Isomer,T2 Toxin,T 2 Toxin,Toxin, T-2,Toxin, T2

Related Publications

A Sintov, and M Bialer, and B Yagen
December 1993, Journal of veterinary pharmacology and therapeutics,
A Sintov, and M Bialer, and B Yagen
April 2006, Journal of veterinary pharmacology and therapeutics,
A Sintov, and M Bialer, and B Yagen
May 2022, Research in veterinary science,
A Sintov, and M Bialer, and B Yagen
March 1983, British journal of clinical pharmacology,
A Sintov, and M Bialer, and B Yagen
April 2006, Journal of veterinary pharmacology and therapeutics,
A Sintov, and M Bialer, and B Yagen
January 2014, Molecules (Basel, Switzerland),
A Sintov, and M Bialer, and B Yagen
January 2009, European journal of drug metabolism and pharmacokinetics,
A Sintov, and M Bialer, and B Yagen
February 2015, Journal of veterinary pharmacology and therapeutics,
A Sintov, and M Bialer, and B Yagen
January 2014, Toxicological sciences : an official journal of the Society of Toxicology,
Copied contents to your clipboard!